Beckman Coulter, East Clare, Ireland

Beckman Coulter invests €10 million in Irish diagnostics facility

Leading diagnostics company Beckman Coulter has announced a substantial €10 million investment in its East Clare facility, reinforcing its commitment to innovation and growth in Ireland’s Mid-West region. The investment will significantly enhance the site’s diagnostics production capabilities, with the addition of two new fully automated reagent filling lines and infrastructure upgrades.

bioconductor

CUNY and Genestack collaborate to enhance BioConductor data curation

Technological partnerships The expansion features Cytiva’s Xcellerex XDR Bioreactor single-use system. Silke Fetzer-Rümpler, Senior Vice President, Commercial at Cytiva, noted the system’s scalability and potential to accelerate clinical and commercial milestones.

Scherm­afbeelding 2024 07 02 om 09.09.07

HEMOCELL | Hemostasis automation that works on so many levels

HemoCell delivers workcell efficiency, quality and standardization for Hemostasis labs.

Scherm­afbeelding 2024 07 02 om 09.45.49

Cystatin C FS

Gold standard for early kidney disease diagnosis

Scherm­afbeelding 2024 07 02 om 09.38.51

EUROIMMUN | EASY. EFFICIENT. EXCEPTIONAL

Scherm­afbeelding 2024 07 02 om 09.26.46

New Generation Hospital Glucose/Ketone Meter

Only glucose meter FDA-cleared for use with critically ill patients

Scherm­afbeelding 2024 07 02 om 08.57.03

Novel DNA-based method revolutionises sepsis diagnosis

Researchers from Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB and partners have developed a groundbreaking approach to identify pathogens in sepsis patients, potentially reducing mortality rates and improving treatment outcomes. The team has been awarded the 2024 Stifterverband Science Prize for their innovative work.

Withaferin A

Scalable synthesis of withanolides: A significant development in cancer research

Researchers at Moffitt Cancer Center have developed a novel method for the scalable synthesis of withanolides, a class of naturally occurring compounds with significant potential in cancer treatment. This groundbreaking approach, published in Science Advances [1], could revolutionise cancer research by providing a reliable and efficient means of producing these vital compounds in large quantities.

Yang Changhuei FPM APIC

Beyond FPM: New imaging technique promises clearer, faster microscopy

A team of engineers at the California Institute of Technology (Caltech) has developed a groundbreaking microscopy method that promises to revolutionise biomedical imaging, digital pathology, and drug screening. The new technique, called Angular Ptychographic Imaging with Closed-form method (APIC), builds upon and surpasses the capabilities of its predecessor, Fourier ptychographic microscopy (FPM).